The ECCK held a press conference on September the 21st for the publication of the 2023 ECCK White Paper, which contains recommendations of European companies regarding the Korean business environment. During the conference, the ECCK explained about the regulatory challenges and industry issues in the Korean market. A total of 100 recommendations and regulatory issues …
On September 15, Brian McEachen, the representative director for Korea of Leonardo participated in Hongreung Defense Forum as a panelist representing the ECCK Aerospace & Defense Committee. This forum was hosted by Korea Institute for Defense Analyses (KIDA) and EU Delegation to the Republic of Korea with the support of the EU Project ‘Enhancing Security …
The ECCK Sustainability Awards 2023 is open until September 29(Friday)! Please submit your application NOW! Click here for detailed information about application guidelines, awards categories, evaluation criteria, awards & prizes, etc. Click here to download the application form Should you have any inquiries or wish to receive more information about the application process, please contact us at ecck@ecck.or.kr and cassandra.talbot@ecck.or.kr. …
On the morning of September 14, the ECCK successfully hosted an info session on “Recent Anti-trust issue & CEO Personal Criminal Risk”. In light of development about the Prosecutor’s Office’s active antitrust law enforcement, we have organized a seminar to analyze the growing personal criminal risks faced by CEOs of foreign companies doing business in …
On September 12, 2023, the ECCK attended the roundtable meeting co-hosted by Incheon City and Korea Times to strengthen global business network and partnership. Mr. Go-Young Moon, Chairperson of ECCK Energy and Environment Committee and Country Chair of RWE joined the meeting with representatives from other foreign chambers and Korean business associations. Mr. Jeong-Bok Yoon, …
On September 8, 2023, the ECCK Healthcare Committee arranged a Roundtable meeting with the Ministry of Health and Welfare(MoH) Pharmaceutical Benefit Division, which is key department for Drug Pricing Policies in Korea. ECCK and the committee members have continuously discussed with MoH regarding current pharma industry issues. Mr. Chang Hyun Oh, a director of MOH …